Advancing Regulatory Science for Medical Countermeasure Development Workshop Summary (2011) / Chapter Skim
Currently Skimming:
6 Closing Remarks
6 Closing Remarks
Pages 79-80
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 79... ...
This is one of the key reasons why it is so important to maintain a robust science program inside FDA. "We strive to keep this program," she said, "despite continued limited resources, downsizing, and budget cuts." Professional development is critical, and it is important for FDA researchers to attend BOX 6-1 Seven Regulatory Science Focus Areas of the FDA MCM Initative (Pillar 2)
|
From page 80... ...
This peer-review process increases the visibility and awareness of partners, thereby creating greater potential for partnerships and collaboration with FDA and across the MCM enterprise as a whole. The success of the FDA MCM initiative will not be dependent solely upon FDA's efforts, Hu-Primmer concluded, explaining that it depends on everyone working together, from informal collaborations to competi tive grants and contracts, and all options in between.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.